# LEE ENTERPRISES, Inc: financial statements, quarterly

LEE · Nasdaq · CIK 58361 · [Communication](/sectors/communication.md) · fiscal year ends Sep 29

Pages: [Overview](/companies/lee.md) · [Financials](/companies/lee/financials.md) · [Filings](/companies/lee/filings.md) · [Insiders](/companies/lee/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lee/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-24) | Q1 FY2024 (2023-12-24) | Q2 FY2024 (2024-03-24) | Q3 FY2024 (2024-06-23) | Q4 FY2024 (2024-09-29) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | Q4 FY2025 (2025-09-28) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [164 d](/filings/0000058361-25-000040.md) | [156](/filings/0001628280-25-004469.md) | [147](/filings/0001628280-25-024179.md) | [151](/filings/0001628280-25-039251.md) | [159 d](/filings/0000058361-25-000040.md) | [145](/filings/0000058361-26-000014.md) | [137](/filings/0000058361-26-000041.md) | [141](/filings/0000058361-26-000060.md) | [139 d](/filings/0000058361-25-000040.md) | [130](/filings/0000058361-26-000014.md) | [122](/filings/0000058361-26-000041.md) | [126](/filings/0000058361-26-000060.md) |
| Operating income | $m | [10.9 d](/filings/0000058361-25-000040.md) | [7.8](/filings/0001628280-25-004469.md) | [(4.6)](/filings/0001628280-25-024179.md) | [4.9](/filings/0001628280-25-039251.md) | [(3.7) d](/filings/0000058361-25-000040.md) | [(3.4)](/filings/0000058361-26-000014.md) | [(4.5)](/filings/0000058361-26-000041.md) | [4.7](/filings/0000058361-26-000060.md) | [(1.5) d](/filings/0000058361-25-000040.md) | [5.2](/filings/0000058361-26-000014.md) | [8.5](/filings/0000058361-26-000041.md) | [8.6](/filings/0000058361-26-000060.md) |
| Interest expense | $m | [10.3 d](/filings/0001628280-23-041119.md) | [10.1](/filings/0001628280-24-003010.md) | [10.2](/filings/0001628280-24-020172.md) | [10.1](/filings/0001628280-25-039251.md) | [10.8 d](/filings/0000058361-25-000040.md) | [10.3](/filings/0000058361-26-000014.md) | [10.0](/filings/0000058361-26-000041.md) | [10.1](/filings/0000058361-26-000060.md) | [10.1 d](/filings/0000058361-25-000040.md) | [10.2](/filings/0000058361-26-000014.md) | [7.6](/filings/0000058361-26-000041.md) | [5.6](/filings/0000058361-26-000060.md) |
| Income tax | $m | [0.9 d](/filings/0000058361-25-000040.md) | [0.2](/filings/0001628280-25-004469.md) | [(2.8)](/filings/0001628280-25-024179.md) | [(0.8)](/filings/0001628280-25-039251.md) | [(4.2) d](/filings/0000058361-25-000040.md) | [3.2](/filings/0000058361-26-000014.md) | [(1.8)](/filings/0000058361-26-000041.md) | [(2.7)](/filings/0000058361-26-000060.md) | [(5.6) d](/filings/0000058361-25-000040.md) | [0.9](/filings/0000058361-26-000014.md) | [3.4](/filings/0000058361-26-000041.md) | [1.4](/filings/0000058361-26-000060.md) |
| Net income | $m | [(2.0) d](/filings/0000058361-25-000040.md) | [0.7](/filings/0001628280-25-004469.md) | [(12.2)](/filings/0001628280-25-024179.md) | [(4.3)](/filings/0001628280-25-039251.md) | [(10.1) d](/filings/0000058361-25-000040.md) | [(16.7)](/filings/0000058361-26-000014.md) | [(12.5)](/filings/0000058361-26-000041.md) | [(1.9)](/filings/0000058361-26-000060.md) | [(6.4) d](/filings/0000058361-25-000040.md) | [(5.6)](/filings/0000058361-26-000014.md) | [(2.1)](/filings/0000058361-26-000041.md) | [4.7](/filings/0000058361-26-000060.md) |
| Diluted EPS | $ per share | not reported | [0.12](/filings/0001628280-25-004469.md) | [(2.06)](/filings/0001628280-25-024179.md) | [(0.73)](/filings/0001628280-25-039251.md) | not reported | [(2.80)](/filings/0000058361-26-000014.md) | [(2.07)](/filings/0000058361-26-000041.md) | [(0.31)](/filings/0000058361-26-000060.md) | not reported | [(0.92)](/filings/0000058361-26-000014.md) | [(0.16)](/filings/0000058361-26-000041.md) | [0.21](/filings/0000058361-26-000060.md) |
| Basic EPS | $ per share | not reported | [0.12](/filings/0001628280-25-004469.md) | [(2.06)](/filings/0001628280-25-024179.md) | [(0.73)](/filings/0001628280-25-039251.md) | not reported | [(2.80)](/filings/0000058361-26-000014.md) | [(2.07)](/filings/0000058361-26-000041.md) | [(0.31)](/filings/0000058361-26-000060.md) | not reported | [(0.92)](/filings/0000058361-26-000014.md) | [(0.16)](/filings/0000058361-26-000041.md) | [0.21](/filings/0000058361-26-000060.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-24) | Q1 FY2024 (2023-12-24) | Q2 FY2024 (2024-03-24) | Q3 FY2024 (2024-06-23) | FY2024 (2024-09-29) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | FY2025 (2025-09-28) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [14.5](/filings/0001628280-24-051167.md) | [15.4](/filings/0001628280-24-003010.md) | [16.1](/filings/0001628280-24-020172.md) | [13.4](/filings/0001628280-24-034325.md) | [9.6](/filings/0000058361-25-000040.md) | [6.1](/filings/0001628280-25-004469.md) | [4.7](/filings/0001628280-25-024179.md) | [14.1](/filings/0001628280-25-039251.md) | [10.0](/filings/0000058361-26-000060.md) | [12.6](/filings/0000058361-26-000014.md) | [53.3](/filings/0000058361-26-000041.md) | [59.4](/filings/0000058361-26-000060.md) |
| Current assets | $m | [107](/filings/0001628280-24-051167.md) | [106](/filings/0001628280-24-003010.md) | [102](/filings/0001628280-24-020172.md) | [102](/filings/0001628280-24-034325.md) | [97.8](/filings/0000058361-25-000040.md) | [92.3](/filings/0001628280-25-004469.md) | [92.8](/filings/0001628280-25-024179.md) | [96.9](/filings/0001628280-25-039251.md) | [89.4](/filings/0000058361-26-000060.md) | [82.9](/filings/0000058361-26-000014.md) | [112](/filings/0000058361-26-000041.md) | [121](/filings/0000058361-26-000060.md) |
| Total assets | $m | [712](/filings/0001628280-24-051167.md) | [703](/filings/0001628280-24-003010.md) | [685](/filings/0001628280-24-020172.md) | [677](/filings/0001628280-24-034325.md) | [649](/filings/0000058361-25-000040.md) | [633](/filings/0001628280-25-004469.md) | [624](/filings/0001628280-25-024179.md) | [623](/filings/0001628280-25-039251.md) | [602](/filings/0000058361-26-000060.md) | [593](/filings/0000058361-26-000014.md) | [619](/filings/0000058361-26-000041.md) | [625](/filings/0000058361-26-000060.md) |
| Current liabilities | $m | [114](/filings/0001628280-24-051167.md) | [113](/filings/0001628280-24-003010.md) | [109](/filings/0001628280-24-020172.md) | [110](/filings/0001628280-24-034325.md) | [115](/filings/0000058361-25-000040.md) | [119](/filings/0001628280-25-004469.md) | [116](/filings/0001628280-25-024179.md) | [118](/filings/0001628280-25-039251.md) | [113](/filings/0000058361-26-000060.md) | [112](/filings/0000058361-26-000014.md) | [98.4](/filings/0000058361-26-000041.md) | [104](/filings/0000058361-26-000060.md) |
| Total liabilities | $m | [688](/filings/0001628280-24-051167.md) | [680](/filings/0001628280-24-003010.md) | [674](/filings/0001628280-24-020172.md) | [671](/filings/0001628280-24-034325.md) | [657](/filings/0000058361-25-000040.md) | [657](/filings/0001628280-25-004469.md) | [660](/filings/0001628280-25-024179.md) | [661](/filings/0001628280-25-039251.md) | [643](/filings/0000058361-26-000060.md) | [639](/filings/0000058361-26-000014.md) | [622](/filings/0000058361-26-000041.md) | [625](/filings/0000058361-26-000060.md) |
| Long-term debt | $m | [456](/filings/0001628280-24-051167.md) | [454](/filings/0001628280-24-003010.md) | [454](/filings/0001628280-24-020172.md) | [450](/filings/0001628280-24-034325.md) | [446](/filings/0000058361-25-000040.md) | [446](/filings/0001628280-25-004469.md) | [453](/filings/0001628280-25-024179.md) | [455](/filings/0001628280-25-039251.md) | [455](/filings/0000058361-26-000060.md) | [455](/filings/0000058361-26-000014.md) | [455](/filings/0000058361-26-000041.md) | [455](/filings/0000058361-26-000060.md) |
| Current portion of debt | $m | [0.0](/filings/0001628280-24-034325.md) | not reported | not reported | [2.6](/filings/0001628280-24-034325.md) | [0.0](/filings/0001628280-25-039251.md) | [0.0](/filings/0001628280-25-004469.md) | not reported | [0.4](/filings/0001628280-25-039251.md) | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [21.2](/filings/0001628280-24-051167.md) | [19.7](/filings/0001628280-24-034325.md) | [7.9](/filings/0001628280-24-034325.md) | [4.0](/filings/0001628280-24-034325.md) | [(9.9)](/filings/0000058361-25-000040.md) | [(26.7)](/filings/0001628280-25-004469.md) | [(38.9)](/filings/0001628280-25-024179.md) | [(40.5)](/filings/0001628280-25-039251.md) | [(43.3)](/filings/0000058361-26-000060.md) | [(48.7)](/filings/0000058361-26-000014.md) | [(5.5)](/filings/0000058361-26-000041.md) | [(2.2)](/filings/0000058361-26-000060.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-24) | Q1 FY2024 (2023-12-24) | Q2 FY2024 (2024-03-24) | Q3 FY2024 (2024-06-23) | Q4 FY2024 (2024-09-29) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | Q4 FY2025 (2025-09-28) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,463) d](/filings/0000058361-25-000040.md) | [80.0](/filings/0001628280-25-004469.md) | [3,200 d](/filings/0001628280-25-024179.md) | [(1,902) d](/filings/0001628280-25-039251.md) | [(261) d](/filings/0000058361-25-000040.md) | [(7,337)](/filings/0000058361-26-000014.md) | [(790) d](/filings/0000058361-26-000041.md) | [8,892 d](/filings/0000058361-26-000060.md) | [(6,306) d](/filings/0000058361-25-000040.md) | [4,471](/filings/0000058361-26-000014.md) | [(6,247) d](/filings/0000058361-26-000041.md) | [7,915 d](/filings/0000058361-26-000060.md) |
| Capital expenditure | $k | [1,316 d](/filings/0000058361-25-000040.md) | [1,030](/filings/0001628280-25-004469.md) | [1,948 d](/filings/0001628280-25-024179.md) | [3,574 d](/filings/0001628280-25-039251.md) | [2,656 d](/filings/0000058361-25-000040.md) | [1,553](/filings/0000058361-26-000014.md) | [1,370 d](/filings/0000058361-26-000041.md) | [616 d](/filings/0000058361-26-000060.md) | [(1,996) d](/filings/0000058361-25-000040.md) | [758](/filings/0000058361-26-000014.md) | [577 d](/filings/0000058361-26-000041.md) | [1,072 d](/filings/0000058361-26-000060.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-25) | Q2 FY2023 (2023-03-26) | Q3 FY2023 (2023-06-25) | Q1 FY2024 (2023-12-24) | Q2 FY2024 (2024-03-24) | Q3 FY2024 (2024-06-23) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [5.9](/filings/0001628280-24-003010.md) | [5.8](/filings/0001628280-24-020172.md) | [5.9](/filings/0001628280-24-034325.md) | [5.9](/filings/0001628280-25-004469.md) | [5.9](/filings/0001628280-25-024179.md) | [5.9](/filings/0001628280-25-039251.md) | [6.0](/filings/0000058361-26-000014.md) | [6.0](/filings/0000058361-26-000041.md) | [6.1](/filings/0000058361-26-000060.md) | [6.1](/filings/0000058361-26-000014.md) | [13.8](/filings/0000058361-26-000041.md) | [22.3](/filings/0000058361-26-000060.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 22,292,044 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0000058361-26-000060.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.